Cannabis-Related Offenses In CT: Bill Seeks To Review Pre-Legalization Weed Convictions
Connecticut legislature’s Judiciary Committee is working on a bill that would reconsider cannabis-related offenses following Gov. Ned Lamont's (D)
MDMA News: Exclusive Supply Deal With Awakn Life Sciences & Canadian Company Expands Psychedelics Production
PharmAla To Be Exclusive MDMA Supply Partner To Awakn Life Sciences
Effective immediately, MDXX class molecules producer PharmAla Biotech Holdings Inc. will become the exclusive MDMA supplier to Awakn Life Sciences (OTCMKTS: AWKNF).
Braxia Scientific’s Q3 2023 Finances, Update On Upcoming Acquisition With Irwin Naturals
Research and telemedicine company Braxia Scientific Corp. (OTC: BRAXF) has filed its financial statements for the third quarter ended Dec.
[Video] Trulieve CEO Kim Rivers Reveals Secrets To Explosive 30% YoY Growth In Latest Interview
Trulieve (OTC: TCNNF) CEO Kim Rivers sat down with Benzinga at the MJ Biz Conference in November 2022 to discuss Trulieve's mission and future expansion, as well as the positive sides of the growing cannabis industry.
2023 Off To A Busy Start: Top Cannabis Execs Making Moves, Will They Attend Benzinga’s April Event?
As the Benzinga Cannabis Capital Conference returns to Miami (April 11-12), gathering top CEOs, investors and leaders in the marijuana industry, let's scroll through some executive moves from the first two mon
Why Cannabis Is Recession-Resistant & Turning Challenges Into Opportunities, Industry Expert Explains
It is safe to say that the cannabis industry would not have progressed as much as it has if it were not for the people who believed in it. Cannabis advocates, lobbyists, growers, operators, consumers and researchers have consistently played a crucial role in the space. Nevertheless, without capital, the industry wouldn’t have advanced to where it is today.
Lexaria’s DehydraTECH-CBD Diabetes Study Demonstrates Weight Loss, Improved Triglyceride And Cholesterol Levels
Lexaria Bioscience Corp.’s (NASDAQ: LEXX) (NASDAQ: LEXXW) diabetes animal model study DIAB-A22-1 has been completed and produced at least three positive outcomes including weight loss in
Wall Street Analyst-Led Research Firm Gives Up On Cannabis, Here’s Why
Cowen Group has discontinued coverage of the cannabis sector following its acquisition by TD Bank Group (TSX: TD) (NYSE: TD) on Wednes
Florida Cannabis Giant Faces Backlash After New Layoffs: Community Outrage And A Corporate Need To Adapt
Only a few days ago, Florida-based cannabis operator Trulieve (OTCQX: TCNNF) fired an unknown number of employees at a customer call center in Clearwater.
Greenway Q3 FY23 Revenue Grows 103% YoY, What About Net Loss?
Greenway Greenhouse Cannabis Corporation (OTCQB: GWAYF) (CSE:GWAY) revenue in Q3 fiscal 2023 was CA$1.04 million, ($763,000) a 103% increase compared to CA$512,656 in Q3 FY 2022.
Q3 FY 2023 Financial Highlights